Literature DB >> 31924719

FAP: the next billion dollar nuclear theranostics target ?

Jeremie Calais1.   

Abstract

Keywords:  FAP; Molecular Imaging; Peptides; Radionuclide Therapy; Radiopharmaceuticals; biological target; molecular imaging; molecular radiotherapy; nuclear theranostics

Year:  2020        PMID： 31924719     DOI： 10.2967/jnumed.119.241232

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  12 in total

1.  Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.

Authors:  Mengxin Xu; Pu Zhang; Jie Ding; Junyi Chen; Li Huo; Zhibo Liu
Journal:  J Nucl Med       Date:  2021-09-30       Impact factor: 11.082

2.  [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity.

Authors:  Zachary T Rosenkrans; Christopher F Massey; Ksenija Bernau; Carolina A Ferreira; Justin J Jeffery; Jefree J Schulte; Melissa Moore; Frank Valla; Jeanine M Batterton; Christopher R Drake; Alan B McMillan; Nathan Sandbo; Ali Pirasteh; Reinier Hernandez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-12       Impact factor: 10.057

3.  State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.

Authors:  Martina Sollini; Margarita Kirienko; Fabrizia Gelardi; Francesco Fiz; Noemi Gozzi; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-25       Impact factor: 9.236

Review 4.  From Theranostics to Immunotheranostics: the Concept.

Authors:  Niklaus Schaefer; John O Prior; Margret Schottelius
Journal:  Nucl Med Mol Imaging       Date:  2020-04-08

5.  Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography.

Authors:  Hallie M Hintz; Joseph P Gallant; Donald J Vander Griend; Ilsa M Coleman; Peter S Nelson; Aaron M LeBeau
Journal:  Clin Cancer Res       Date:  2020-07-07       Impact factor: 12.531

6.  An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications.

Authors:  Jacopo Millul; Gabriele Bassi; Jacqueline Mock; Abdullah Elsayed; Christian Pellegrino; Aureliano Zana; Sheila Dakhel Plaza; Lisa Nadal; Andreas Gloger; Eleonore Schmidt; Ilaria Biancofiore; Etienne J Donckele; Florent Samain; Dario Neri; Samuele Cazzamalli
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

7.  FAP-targeted radionuclide therapy with [177Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma.

Authors:  Kaili Fu; Yizhen Pang; Liang Zhao; Limei Lin; Hua Wu; Long Sun; Qin Lin; Haojun Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-08       Impact factor: 9.236

Review 8.  Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review.

Authors:  Liang Zhao; Jianhao Chen; Yizhen Pang; Kaili Fu; Qihang Shang; Hua Wu; Long Sun; Qin Lin; Haojun Chen
Journal:  Theranostics       Date:  2022-01-09       Impact factor: 11.556

9.  Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond.

Authors:  Chunxia Qin; Yangmeihui Song; Xi Liu; Yongkang Gai; Qingyao Liu; Weiwei Ruan; Fang Liu; Fan Hu; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-09       Impact factor: 10.057

Review 10.  Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy.

Authors:  Sofia Koustoulidou; Mark W H Hoorens; Simone U Dalm; Shweta Mahajan; Reno Debets; Yann Seimbille; Marion de Jong
Journal:  Cancers (Basel)       Date:  2021-03-04       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.